Cue Biopharma, Inc. (CUE) Insider Trading

Name: Cue Biopharma, Inc. (CUE) insider trading: SEC Form 4 filings
Creator: Insiders Notifier
License: https://www.sec.gov/privacy#dissemination

Latest Form 4 (Aug 17, 2026): Ray Sumita (Chief Legal Compliance Officer): Exercise/Conversion of 18,196 shares.

Get alerted when insiders trade CUE

Email address

Loading company data...

Beta

Loading company details...

Beta